Stocks and Investing
Stocks and Investing
Fri, August 16, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (avbp) at Strong Buy with Increased Target to $30 on, Aug 16th, 2024
Robert Burns of HC Wainwright & Co., Maintained "ArriVent BioPharma, Inc." (AVBP) at Strong Buy with Increased Target from $25 to $30 on, Aug 16th, 2024.
Robert has made no other calls on AVBP in the last 4 months.
There is 1 other peer that has a rating on AVBP. Out of the 1 peers that are also analyzing AVBP, 0 agree with Robert's Rating of Hold.
This is the rating of the analyst that currently disagrees with Robert
- Jeff Jones of "Oppenheimer" Reiterated at Buy and Held Target at $35 on, Thursday, August 15th, 2024
Contributing Sources